Therapeutic Solutions International, Inc. TSOI
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.0001 Day range 0.0001
0.00001 52-week range 0.0001
- YTD
- -90.00%
- 1 year
- -90.00%
- Market cap
- 51.23K
- YTD return
- -90.00%
- 1-year return
- -90.00%
- Volume
- 9.40M
- Avg volume
- 4.26K
- Open
- 0.0001
- Previous close
- 0.00001
- Day's range
- 0.0001 – 0.0001
- 52-week range
- 0.00001 – 0.0001
2Y -0.0007 (-98.67%)
News
Therapeutic Solutions International to Voluntarily Delist 
Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases 
Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients 
Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product 
Therapeutic Solutions International Files Patent on “Facilitating Effects” of JadiCells on Gene Therapy Mediated Cell Differentiation 
Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities 
Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene™ 
Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease 
Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression 
Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using mRNA
Your note
Sign in to keep a note on TSOI — it syncs with the Stock Master app.